Alpharma Inc.

144 articles about Alpharma Inc.

• 

  CEOs, Directors and Other Senior Executives Tapped by Biotech

  5/21/2018

  Pharma and biotech companies across the globe continued to expand and reshape their leadership teams with new hires this past week. BioSpace collected several announced leadership appointments, which includes new chief executive officers, new members to boards of directors and more.

• King Pharmaceuticals®, Inc. Unit, Alpharma Inc. to Pay $42.5 Million Over Kadian Claims

  3/17/2010

• King Pharmaceuticals®, Inc. Completes Acquisition of Alpharma Inc.

  12/30/2008

• Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals®, Inc.’s Acquisition of Alpharma Inc.

  12/29/2008

• King Pharmaceuticals®, Inc. Extends Tender Offer for Alpharma Inc.

  12/22/2008

• King Pharmaceuticals®, Inc.To Acquire Alpharma Inc. for Approximately $1.6 Billion

  11/24/2008

• US FDA Staff Cite Abuse Concerns With Alpharma Inc. Drug Embeda

  11/12/2008

• Alpharma Inc. 3rd-Quarter Profit Falls but Exceeds Forecast

  10/29/2008

• Alpharma Inc. Announces Information for Third Quarter 2008 Earnings Conference Call

  10/27/2008

• King Pharmaceuticals®, Inc. Extends Tender Offer to Acquire Alpharma Inc.

  10/13/2008

• Alpharma Inc. and King Pharmaceuticals®, Inc. Enter into Confidentiality Agreement

  10/6/2008

• Alpharma Inc. Rejects King Pharmaceuticals®, Inc.'s Offer as Inadequate

  9/26/2008

• Alpharma Inc. to Develop and Commercialize DURECT Corporation's ELADUR(TM) Pain Patch

  9/22/2008

• King Pharmaceuticals®, Inc. Ups Alpharma Inc. Offer to $1.6 Billion, Goes Hostile

  9/12/2008

• King Pharmaceuticals®, Inc. Ups Alpharma Inc. Offer, Will Go to Shareholders

  9/11/2008

• Alpharma Inc. Urges Shareholders to Take No Action with Respect to King Pharmaceuticals®, Inc.' Announced Intent to Commence a Tender Offer

  9/11/2008

• Alpharma Inc. Reports Positive Embeda Pain Drug Data

  9/10/2008

• Alpharma Inc. Adopts Rights Plan to Thwart King Pharmaceuticals®, Inc. Bid

  9/2/2008

• Alpharma Inc. Adopts Limited Duration Shareholder Rights Plan

  9/2/2008

• King Pharmaceuticals®, Inc. Provides Updated Replay Information for Conference Call Regarding Proposed Acquisition of Alpharma Inc.

  8/25/2008